Clofranil
$ 47,00 – $ 318,00Price range: $ 47,00 through $ 318,00
Clonidine
$ 40,00 – $ 95,00Price range: $ 40,00 through $ 95,00
Clomid
$ 45,00 – $ 255,00Price range: $ 45,00 through $ 255,00
Clomid is a widely recognized medication specifically designed to assist women who experience difficulties with ovulation. This non-steroidal fertility agent works by stimulating the release of essential hormones required for the ovaries to produce and release an mature egg. It is primarily indicated for the treatment of ovulatory dysfunction in patients who are seeking to achieve pregnancy. By promoting regular ovulation cycles, the medication significantly increases the chances of successful conception for those facing certain types of infertility. As a trusted option in reproductive health, Clomid helps restore the natural physiological process necessary for starting a family.
Active substance: Clomiphene
SKU:
Clomid
Categories: BestSellers, Woman's Health
Delivery: 5–21 days (depending on the shipping method)
Extra 10% discount with coupon: IT4K6SVM
Each dosage option has its own packaging choices.
Description
Clomid belongs to a class of medications known as selective estrogen receptor modulators (SERMs), specifically classified as ovulation stimulants. It is a prescription-only medication approved by the U.S. Food and Drug Administration (FDA) for the treatment of ovulatory dysfunction in women who wish to become pregnant.
Proper diagnostic evaluation of thyroid dysfunction, adrenal disorders, hyperprolactinemia, and male factor infertility should precede therapy with this agent. Because therapy requires precise clinical supervision and timing, it must be taken strictly in accordance with federal and state prescription regulations under the supervision of a licensed healthcare provider.
| Attribute | Specification |
|---|---|
| Active ingredient | Clomiphene citrate |
| Therapeutic class | Selective Estrogen Receptor Modulator (SERM) / Ovulation Stimulant |
| Dosage form | Oral tablet |
| Route of administration | Oral |
| Prescription status | Prescription (Rx) only |
| Primary purpose | Induction of ovulation in women with ovulatory failure |
Pharmacological Profile and Therapeutic Use
How the drug works
Clomid exerts its therapeutic effect by acting as a selective estrogen receptor modulator with both estrogenic and antiestrogenic properties. The primary clinical mechanism involves competitive binding to estrogen receptors located within the hypothalamus. By occupying these receptor sites, clomiphene citrate blocks the negative feedback effect of circulating endogenous estrogens. This perceived deficit in circulating estrogen signals the hypothalamus to increase the pulsatile secretion of gonadotropin-releasing hormone (GnRH).
The elevation of GnRH subsequently stimulates the anterior pituitary gland to synthesize and release higher quantities of follicle-stimulating hormone (FSH) and luteinizing hormone (LH). The surge in FSH and LH promotes the growth, maturation, and development of ovarian follicles within the ovary. Ultimately, this endocrine cascade triggers the preovulatory LH surge, leading to follicular rupture and the release of a mature oocyte (ovulation).
What it’s used for
Clomid is FDA-approved for the treatment of ovulatory dysfunction in women who desire pregnancy. Clinical eligibility requires that the patient’s female partner or candidate exhibits anovulation or oligo-ovulation, provided that primary ovarian failure has been ruled out and the sexual partner exhibits adequate fertility parameters. It is commonly indicated in conditions such as polycystic ovary syndrome (PCOS) and hypothalamic amenorrhea when endogenous estrogen production remains sufficient.
Off-label use: Healthcare providers may occasionally prescribe clomiphene citrate off-label for the management of male hypogonadism or male idiopathic infertility. In male patients, the blockade of central estrogen receptors stimulates pituitary LH release, which in turn acts on Leydig cells in the testes to enhance endogenous testosterone production and support spermatogenesis. Off-label prescribing must be explicitly evaluated by a physician.
Dosing schedule
The standard initial FDA-recommended dosage of Clomid is 50 mg (one tablet) taken orally once daily for a duration of 5 consecutive days. Treatment is typically initiated on or near the fifth day of a menstrual cycle (either spontaneous or induced by progestin withdrawal). If ovulation occurs at the 50 mg daily dose, there is no clinical benefit to increasing the dosage in subsequent cycles.
If ovulation does not occur following the initial 5-day course, a second treatment cycle of 100 mg daily for 5 days may be initiated after a minimum of 30 days, provided pregnancy has been excluded. Dosages exceeding 100 mg daily or treatment durations beyond 5 days per cycle are not recommended by official labeling. Clinical response should be re-evaluated after 3 to 6 treatment cycles; long-term continuous therapy is generally not recommended.
What happens in the body
Following oral administration, clomiphene citrate is readily absorbed from the gastrointestinal tract. The compound consists of two racemic isomers, zuclomiphene and enclomiphene, which exhibit distinct pharmacokinetic profiles and elimination rates. The enclomiphene isomer is cleared rapidly, whereas the zuclomiphene isomer persists in the systemic circulation for significantly longer periods.
Clomiphene citrate is extensively metabolized in the liver. Excretion occurs primarily through the feces via biliary secretion, with a smaller fraction cleared through the kidneys in urine. Due to enterohepatic recirculation and the long biological half-life of the zuclomiphene component, trace amounts of the drug and its metabolites remain detectable in the body for several weeks following completion of a 5-day dosing cycle.
Safety, Precautions, and Clinical Guidance
Compatibility with other medicines
Formal drug interaction studies for clomiphene citrate are limited in official product documentation. Caution is warranted when co-administering Clomid alongside other ovulation-inducing agents or fertility medications (such as injectable exogenous gonadotropins), as simultaneous use significantly increases the risk of severe ovarian hyperstimulation syndrome (OHSS). Patients must inform their prescribing physician of all ongoing treatments, including over-the-counter preparations, herbal products, and prescription medications, to avoid potential therapeutic overlap or adverse reactions.
What side effects may occur
Adverse reactions associated with Clomid therapy are primarily related to its antiestrogenic activity and ovarian stimulation. The most frequently reported adverse effect is vasomotor flushes (hot flashes), occurring in a notable percentage of patients. Other common side effects include pelvic or abdominal discomfort, abdominal distension, bloating, and transient ovarian enlargement due to follicular growth.
Nausea, vomiting, breast discomfort, headache, and breakthrough uterine bleeding or spotting may also occur. A small proportion of patients experience visual disturbances, such as blurred vision, scotomas (blind spots), or visual flashes. Rare but serious risks include severe Ovarian Hyperstimulation Syndrome (OHSS), characterized by marked ovarian enlargement, fluid accumulation in the abdomen and chest, electrolyte imbalance, and hemoconcentration. Multiple pregnancies (most commonly twins) occur at a higher rate with Clomid than in spontaneous conceptions.
Important precautions
Clomid is strictly contraindicated in women who are currently pregnant, as administration during pregnancy may pose risk to the fetus. It is also contraindicated in patients with active liver disease or a history of hepatic dysfunction, unexplained abnormal uterine bleeding, ovarian cysts or enlargement not attributed to polycystic ovary syndrome, and uncontrolled thyroid or adrenal dysfunction.
Patients who experience visual symptoms such as blurring or spots while taking Clomid must discontinue the medication immediately and contact their physician for an ophthalmic evaluation. Driving or operating complex machinery should be performed with caution if visual disturbances or dizziness occur during therapy.
First days of treatment
During the initial days of a 5-day treatment cycle, patients typically tolerate the medication well. Mild symptoms such as transient hot flashes or mild pelvic heaviness may begin to manifest toward the end of the 5-day course or shortly thereafter. Healthcare providers usually recommend tracking basal body temperature, utilizing urinary luteinizing hormone (LH) surge predictor kits, or undergoing transvaginal ultrasound monitoring to accurately pinpoint the window of ovulation, which generally occurs 5 to 10 days after the final tablet is taken.
If you skip a dose
If a dose of Clomid is missed during the 5-day cycle, the patient should contact their prescribing clinician or pharmacist for guidance. If remembered on the same day, the missed dose is typically taken as soon as recognized. However, patients should never take two doses at the same time or add extra tablets to compensate for a skipped dose. Omitting a dose may affect the timing of follicular maturation and ovulation prediction.
Pregnancy, breastfeeding, and other groups
Clomid is contraindicated during pregnancy; a pregnancy test must be performed before commencing each treatment cycle. Clomiphene citrate may suppress lactation in nursing mothers, and it is excreted in human milk; therefore, it is not recommended for use during breastfeeding. Safety and effectiveness in pediatric patients have not been established. The drug is not indicated for use in postmenopausal geriatric populations.
What to ask your provider
Patients preparing to start treatment may benefit from discussing the following clinical questions with their physician:
- What diagnostic monitoring (e.g., blood tests, ultrasounds) will be performed during this cycle?
- What specific day after completing the tablets should ovulation be anticipated?
- What physical signs indicate that treatment should be stopped immediately?
- How many total cycles of Clomid are considered appropriate for my clinical situation?
Common questions
Q: How long after finishing the 5-day course does ovulation usually happen?
A: Ovulation typically occurs between 5 and 10 days following the administration of the last Clomid tablet in the cycle. Clinical monitoring, such as tracking ovulation predictor kits or ultrasound evaluation, helps pinpoint this timing for scheduled intercourse or intra-uterine insemination.
Q: Does Clomid increase the probability of multiple births?
A: Yes. Treatment with Clomid carries an increased risk of multiple gestation compared to natural conception. The majority of multiple pregnancies resulting from clomiphene therapy are twin pregnancies, though triplets or higher-order multiples can occasionally occur.
Q: What should be done if visual symptoms develop while taking this medication?
A: If visual symptoms such as blurred vision, double vision, spots, or light sensitivity occur, the patient must stop taking Clomid immediately and notify their prescribing provider. An ophthalmologic examination may be required before any further treatment is considered.
Q: What actions are required if a pregnancy test is positive during a cycle?
A: If a patient suspects pregnancy or obtains a positive pregnancy test, Clomid must not be taken for any subsequent cycles. The patient should contact their healthcare provider immediately to confirm the pregnancy and initiate appropriate prenatal care.
Q: Can Clomid tablets be taken with food?
A: Clomid may be taken with or without food. Taking the tablet with a meal or a glass of water may help reduce minor gastrointestinal upset such as mild nausea.
In accordance with FDA requirements.
This text is for informational purposes only and does not constitute individual medical advice.
Additional information
| Dosage |
25mg ,50mg ,100mg |
|---|---|
| Package |
10 pills ,20 pills ,30 pills ,60 pills ,90 pills ,120 pills ,180 pills ,270 pills ,360 pills |
| Ενεργός Ουσία |
Related products
Alesse
$ 65,00 – $ 208,00Price range: $ 65,00 through $ 208,00
Active substance: ethinyloestradiol, Levonorgestrel
More Details
This product has multiple variants. The options may be chosen on the product page
Alkeran
$ 112,00 – $ 513,00Price range: $ 112,00 through $ 513,00
Active substance: Melphalan
More Details
This product has multiple variants. The options may be chosen on the product page
Calcium Carbonate
$ 41,00 – $ 535,00Price range: $ 41,00 through $ 535,00
Active substance: Calcium Carbonate
More Details
This product has multiple variants. The options may be chosen on the product page
Careprost
$ 42,00 – $ 367,00Price range: $ 42,00 through $ 367,00
Active substance: Bimatoprost
More Details
This product has multiple variants. The options may be chosen on the product page
Female Cialis
$ 20,00 – $ 340,00Price range: $ 20,00 through $ 340,00
Active substance: Tadalafil
More Details
This product has multiple variants. The options may be chosen on the product page
Female Cialis Soft
$ 40,00 – $ 288,00Price range: $ 40,00 through $ 288,00
Active substance: Tadalafil
More Details
This product has multiple variants. The options may be chosen on the product page
Femalefil
$ 46,00 – $ 89,00Price range: $ 46,00 through $ 89,00
Active substance: Tadalafil
More Details
This product has multiple variants. The options may be chosen on the product page
Fertigyn HP
$ 50,00 – $ 130,00Price range: $ 50,00 through $ 130,00
Active substance: Human Chorionic Gonadotrophin
More Details
This product has multiple variants. The options may be chosen on the product page
